AtriCure to Announce Second Quarter 2014 Financial Results
WEST CHESTER, Ohio -- July 3, 2014
AtriCure, Inc. (Nasdaq: ATRC), a leading atrial fibrillation medical device
provider, will release its financial results for the second quarter of 2014 on
Thursday, July 24, 2014.
AtriCure will host a conference call at 4:30 p.m. Eastern Time on Thursday,
July 24, 2014 to discuss its second quarter 2014 financial results. A live
webcast of the conference call will be available online from the investor
relations page of AtriCure’s corporate website at www.atricure.com. You may
also access this call through an operator by calling (877) 703-6106 for
domestic callers and (857) 244-7305 for international callers at least 15
minutes prior to the call start time using reservation code 59442407.
The webcast will be available on AtriCure’s website and a telephonic replay of
the call will be available through August 24, 2014. The replay dial-in numbers
are (888) 286-8010 for domestic callers and (617) 801-6888 for international
callers. The reservation code is 56506328.
About AtriCure, Inc.
AtriCure, Inc. is a medical device company providing innovative atrial
fibrillation (Afib) solutions designed to produce superior outcomes that
reduce the economic and social burden of atrial fibrillation. AtriCure’s
Synergy Ablation System is the first and only device approved for the
treatment of Persistent and Longstanding Persistent forms of Afib in patients
undergoing certain open concomitant procedures. AtriCure’s AtriClip Left
Atrial Appendage (LAA) exclusion device is the most widely implanted device
for LAA management worldwide. The company believes cardiothoracic surgeons are
adopting its ablation and LAA management devices for the treatment of Afib and
reduction of Afib related complications such as stroke. Afib affects more than
5.5 million people worldwide.
Andy Wade, 513-755-4564
Vice President and Chief Financial Officer
Investor Relations Contact:
Lynn Pieper, 415-202-5678
Press spacebar to pause and continue. Press esc to stop.